<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>t(3;21)(q26;q22) is a recurrent chromosomal abnormality in Philadelphia-positive <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> and in treatment-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular consequences of the t(3;21) are presently being unravelled; various transcripts between the AML1 gene in 21q22 and several unrelated genes, i.e. EAP, EVI1 and MDS1, in 3q26 are generated, resulting in the formation of a chimaeric transcription factor </plain></SENT>
<SENT sid="2" pm="."><plain>The t(3;21) has only rarely been described in de novo <z:mpath ids='MPATH_336'>leukaemias</z:mpath> and never before in an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> in a child </plain></SENT>
<SENT sid="3" pm="."><plain>We here present the clinical, cytogenetic and molecular genetic findings in a boy with a de novo <z:hpo ids='HP_0011009'>acute</z:hpo> monoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> with t(3;21)(q26;q22) and AML1 rearrangement </plain></SENT>
</text></document>